Linkedin Facebook Contact with Pharma Industrial India
 

Last edition

March-April, 2026
All magazines
Subscribe to our magazine
autodoc
 
Home › News › Regulation

CuraTeQ Biologics Secures CDSCO Approval for Bevqolva

CuraTeQ Biologics Secures CDSCO Approval for Bevqolva

CuraTeQ Biologics, a wholly owned subsidiary of Aurobindo Pharma, has announced that the Central Drugs Standard Control Organisation (CDSCO) has granted Marketing Authorisation under Form CT 23 for Bevqolva, a bevacizumab biosimilar indicated for metastatic carcinoma of the colon or rectum.

The authorisation permits manufacture at CuraTeQ’s facility in Hyderabad and marketing of Bevqolva in 100 mg/4mL and 400 mg/16 mL vial presentations.
Read more on:
Aurobindo Pharma Bevacizumab biosimilar approval Bevqolva CDSCO marketing authorisation Colorectal cancer CuraTeQ Biologics Metastatic colorectal cancer treatment
More news about: regulation | Published by News Bureau | May - 16 - 2026

Last news about this category

EU Approves Sanofi's Sarclisa SC as First On-Body Injector Cancer Therapy EU Approves Sanofi's Sarclisa SC as First On-Body Injector Cancer Therapy
US FDA Approves Pfizer's HYMPAVZI for Treatment of Additional Hemophilia A and B Patients US FDA Approves Pfizer's HYMPAVZI for Treatment of Additional Hemophilia A and B Patients
Zai Lab Secures China Approval for TIVDAK Zai Lab Secures China Approval for TIVDAK
Mabwell's 9MW5211 Gains NMPA IND Clearance for Inflammatory Bowel Disease Mabwell's 9MW5211 Gains NMPA IND Clearance for Inflammatory Bowel Disease
Chiesi Global Rare Diseases Announces EC Approval of Lojuxta Capsules Chiesi Global Rare Diseases Announces EC Approval of Lojuxta Capsules
Akums Secures European CEP Approval for Cefpodoxime Proxetil API Akums Secures European CEP Approval for Cefpodoxime Proxetil API
IntraBio Submits EMA Variation Application for AQNEURSA in Ataxia-Telangiectasia IntraBio Submits EMA Variation Application for AQNEURSA in Ataxia-Telangiectasia
Alembic Pharma Receives USFDA Approval for Haloperidol Tablets Alembic Pharma Receives USFDA Approval for Haloperidol Tablets
US FDA Releases Draft Guidance to Accelerate Cell and Gene Therapy Development US FDA Releases Draft Guidance to Accelerate Cell and Gene Therapy Development
WHO Invites Medicine Submissions to Expand Substance Use Disorder Treatment WHO Invites Medicine Submissions to Expand Substance Use Disorder Treatment
 

 

We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.

More information: Privacy Policy

 pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members

Privacy Policy | Cookies Policy